SlideShare a Scribd company logo
1 of 55
수유 중 약물 복용의 상담 원칙
안 현경
임신 중 모유수유 계획율
99.7
68.9
59.0
36.4
14.1
10.2
6.5
12.7
37.4
46
0.0
20.0
40.0
60.0
80.0
100.0
1970 1982 1985 1988 1997 2000 2002 2005 2007 2009
모유수유율
Healthy People 2010 Goals
• Increase to at least 75% the proportion of mothers
breastfeeding upon discharge and 50% still breastfeeding
when the infant is 6 months of age.
0
10
20
30
40
50
60
70
80
90
100
1970 1995 1998 2010
Goal
Discharge
6 Months
모유수유 중단요인
• 의료인의 권유
• 젖이 모자라서
• 함몰 유두
• 젖을 못 빨아서
• 물 젖이어서
• 유두가 아파서
• 기타
37.1%
18.8%
12.1%
10.5%
7.0%
6.1%
8.4%
이승주 등. 소아과 40: 1336
Obstacles to Initiating and Continuing Breastfeeding
• Physician apathy and misinformation
• Insufficient pre-natal breastfeeding education
• Distribution and promotion of infant formula
• Disruptive hospital policies
• Inappropriate interruptions of breastfeeding
• Early hospital discharge
• Lack of social support
Role of the Physician
• Establish positive attitudes in pregnancy
• Address medical issues/ physical obstacles
• Encourage nursing immediately after delivery
• Provide post-partum support
• Explain nutritional needs
• Assess substance use
• Discuss employment concerns
Establish Positive Attitudes
• Endorse and encourage breastfeeding because
it is best for mother and baby.
• Ask about previous experience
• Provide positive statements about breastfeeding
• Offer confirmatory words from all office staff
• Distribute appropriate education materials
• Be supportive no matter what the woman plans
General Benefits of Breastfeeding
• Maternal-infant bonding
• Inexpensive
• Convenient (no preparation)
• Perfect temperature
• Easily digested
• Immunological protection
• Allergy prophylaxis
Breastfeeding Advantages for Mothers
• May delay return of ovulation.
• Loss of pregnancy associated adipose tissue.
• Reduction in postpartum blood loss due to
increased oxytocin levels.
• Reduction in pre-menopausal breast cancer
and reduced risk of ovarian cancer.
• Improved bone remineralization postpartum.
Immunological Contents of Breast Milk
• Immunoglobulins
– IgA, IgG, IgM, leukocytes, cytokines
• Host resistance factors
– Complement macrophages, lymphocytes, lactoferrin
• Anti-inflammatory components
– Enzymes:
catalase, histaminase, lysozymes, lactoperoxidase
– Antioxidants: acsorbic acid, alpha-tocopherol
– Prostoglandins
• Interleukin-6
– Stimulates an increase in mononuclear cells in breast
milk.
Breastfeeding Advantages for Baby
• Decreased incidence and/or severity of otitis
media, diarrhea, lower respiratory
infections, bacteremia, bacterial
meningitis, botulism, urinary tract infections, and
necrotizing enterocolitis.
• Less hospitalization in first 6 months.
• Possible protective effect against sudden infant death
syndrome, type 1 diabetes, Crohn’s
disease, ulcerative colitis, lymphoma, allergies, and
chronic digestive diseases.
Drugs in Breastfeeding
• Healthcare professionals should always encourage
breastfeeding
• Most drugs excreted into breast milk but usually in small
amounts
• Few drugs are absolutely contra-indicated
• Some drugs may increase or decrease milk yield.
Background - Mothers
• 90% of women are prescribed a medication in first week
postpartum
• Mothers worry about effect of medication on nursing
infant
• Leads to: non compliance, weaning, avoidance of
breastfeeding
• 50% of mothers more reluctant to take a medication
while nursing than during pregnancy
Seven contraindications to breastfeeding (AAP 2
005)
• Mother HIV + (in USA)
• Use of illegal drugs by mother
• Certain medications
• Active, untreated TB in mother
• Galactosemia in baby
• Mother HTLV +
• Herpes on breast
How to decide if a medication
or drug is ok?
• Pharmacokinetic factors
• Factors which govern drug transfer across membranes
into breast milk as well as the metabolism of the drug in
mother and infant
Pharmacokinetic factors
1. Passive diffusion
2. Molecular weight
3. Protein binding
4. Lipid solubility
5. Half life
6. Oral bioavailability
Passive diffusion
• Drugs move in and out of
breast milk
• High to low
• With time direction may
shift
• Example: alcohol
Molecular weight
• High molecular weight limits movement into breast milk
• MW >500 daltons does not enter breast milk
Molecular weight: examples
• Insulin: MW > 6,000 daltons
• Heparin: MW 40,000 daltons
• Ethanol: MW 200
Protein binding
• Medications circulate in maternal circulation bound or
unbound to albumin
• Only unbound drug gets into maternal milk
• Definition of good protein binding = > 90%
Protein binding
High protein binding
• Propranolol 90% L2
• Diazepam 99% L3
Low protein binding
• Lithium 0% L3
Lipid solubility
• Drugs that are very lipid soluble penetrate into breast
milk in higher concentration
• Drugs that are active in the CNS are drugs with high lipid
solubility
Half life
Short half life drugs
• Alcohol 24 min
• Keflex 50 min
• Ibuprofen 120 min
• General anesthesia
Long half life drugs
• Prozac 216 hours
Oral bioavailability
• Amount of drug that is absorbed from the gut into the
blood stream
Oral bioavailability
Drug
Maternal GI Tract
Maternal Plasma
Breast Milk
Infant GI Tract
Infant Plasma
Oral bioavailability
• Low bioavailability may be due to
– Reduced absorption in GI tract
– Poor GI stability due to acidity
– High first-pass uptake by liver
Poor oral bioavailability
• Gentamycin
– <1% oral bioavailability
• Insulin (destroyed in gut)
– 0% oral bioavailability
• Heparin (destroyed in gut)
Drug
Maternal gut and liver
Maternal plasma
Infant gut
Infant plasma
Oral bioavailability varies
High (>90%) Low (<50%)
Acetaminopen Acyclovir Lorazepam
Azithromycin
Metronidazole Budesonide
Minoxidil Sulfasalazine
Dilution of all drugs leads to low
concentrations in mother’s plasma
Only drugs are not protein-bound
can pass into milk
Drug protein binding
High Low
Bepridil >99% Bisoprolol 30%
Diazepam 99% Cyclophosphamide 13%
Diclofenac >99% Ranitidine 15%
Propranolol 90% Primidone <20%
Oral bioavailiability varies
Usually very low levels
(often undetectable)
Route of drugs from mother to baby via breastmilk
In general, baby gets <1%
of maternal dose of drug
Choice of Drug
• Short acting
• Highly protein bound
• Low lipid solubility
• High molecular weight
• No active metabolites
• Low oral bioavailability
• Route of administration
Drugs in Lactation – Factors to consider
• Avoid unnecessary drug use and limit use of OTC products
• Assess the benefit/risk ratio for both mother and infant
• Avoid use of drugs known to cause serious toxicity in adults or
children
• Drugs licensed for use in infants do not generally pose a hazard
• Neonates (esp premature infants) are at greater risk from exposure
to drugs via breast milk
• Route of administration (minimum amount of drug to the infant)
• Avoid long-acting preparations
• Monitor Infants exposed to drugs via breast milk for unusual
signs/symptoms
• Avoid new drugs if possible
Drug transfer into the breast milk
• Maternal factor
– Dose and duration of therapy
– Route of administration
– Drug pharmacokinetics
• Infant factor
– Infant’s ability to absorb, metabolize, and excrete the drug
– Gestational age of infant and its postnatal age
Way to minimize infant drug exposure
• Avoid feeding the infant at the time of peak concentration of the drug
in milk.
• Withhold breastfeeding temporarily if the drug is only used for a
short duration.
• Choose drugs for the mother that have known and established
information about their pharmacokinetics and toxicity and have low
concentrations in breast milk and low relative infant dose
• Choose drugs that can be locally rather than systemically
administered
• In case of long-acting drugs, time the drug administration to a once-
a-day dose just before the infant’s longest sleep period to lessen
exposure.
Evaluation of the infant
• Infant age
– Premature and newborn infants are at somewhat greater risk
• Infant stability
– Unstable infants with poor GI stability may increase the risk of
using medications
• Pediatric approved drugs
– Generally are less hazardous if long-term history of safety is
recognized
• Dose
– In a premature infant various doses may be more risky than in a
1 year old healthy infant
• Drugs that alter milk production
– May be much more risky during neonatal period than much later
Summary
• Nearly all drugs pass into human milk
• Almost all medication appears in small amounts, usually less than
1% of the maternal dose
• Very few drugs are contraindicated for nursing mothers
LACTATION RISK CATEGORY
BY THOMAS W HALE
• L1 safest
• L2 safer
• L3 moderately safe
• L4 possibly hazardous
• L5 contraindicated
DRUG CLASSIFICATION BY AAP
• Cytotoxic drugs
• Drugs of abuse for which adverse effects on the infant
• Radioactive compounds that require temporary cessation of
breastfeeding
• Drugs for which the effect on nursing infants in unknown but may be
concern
• Drugs that have been associated with significant effects on some
nursing infants and should be given to nursing mothers with caution
• Maternal medication usually compatible with breastfeeding
상담 시 주지 사항 및 상담내용
• 약을 꼭 복용해야 하는지 평가한다.
• 젖을 빨리고 난 다음 약을 복용한다.
• 약물을 단기간 사용 할 경우에는 수유를 잠시 멈춘다.
• 정확한 정보가 있는 약으로 아이에게 영향이 적은 약을 선택하게 한다.
• 전신적으로 작용하는 약보다는 국소적으로 작용하는 약을 선택하게 한다.
Reasons for using the telephone line
in breastfeeding women
Hemorrhoid
CV disease
GI disease
Contraception
Hepatitis B
Respiratory disease
Others
Psychotic disease
Nutrition
Breast problem
Dental disease
Pain
Inflamation
Dermatologic disease
Thyroid disease
12.5%
11%
9.6%
7.4%
Antihistamine
Regional agents
Miscellaneous
CV agents
Nutritional agents
Natural & Herbal pro
Endocrine agents
Respiratory agents
Systemic antibiotics
CNS agents & Analges
GI drugs
Drugs prescribed for breastfeeding women
Drugs to avoid in the newborn and
in infants < 6months of age
• Beta-blocking agents
– Acebutolol
– Atenolol
– Labetalol
– Propranolol
– Sotalol
• Salicylates
• Lithium
• Antineoplastic agents
• Drugs of abuse
Cytotoxic drugs that may interfere
with cellular metabolism of the nursing infant
 Cyclophosphamide
 Cycloserine
 Doxorubicin
 Methotrexate
Drugs of abuse for which adverse effects on the infant
during breastfeeding have been reported
Drug Reported effect or reasons for concern
Amphetamine Irritability, poor sleeping pattern
Cocain Cocaine intoxication: irritability, vomiting, diarrhea,
tremulousness. seizure
Heroin Tremous, restlessness, vomiting, poor feeding
Marijuana Only 1 report in literature; no effect mentioned; very
long half-life for some components
Phencyclidine Potent hallucinogen
AAP Clssification
Radioactive compounds that require
temporary cessation of breastfeeding
 Copper 64
 Gallium 67
 Indium 111
 Iodine 123
 Iodine 125
 Iodine 131
 Technetium 99
 Radioactive sodium
Anti-anxiety antidepressants antipsychotic Others
Alprazolam
Diazepam
Lorazepam
Midazolam
Perphenazine
Prazepam
Quazepam
Temazepam
Amitryptiline
Amoxapine
Bupropion
Clomipramine
Desipramine
Dothepine
Doxepine
Fluoxetine
Fluvoxamine
Imipramine
Nortriptyline
Paroxetine
Sertraline
Trazodone
Chloropromazine
Chlorprothixene
Clozapine
Haloperidol
Mesoridazine
Trifluoperazine
Amiodarone
Chloramphenicol
Clofazimine
Lamotrigine
metronidazole
Metoclopramide
Tinidazole
Drugs for which the effect on nursing infants is unknown but
may be of concern
AAP Clssification
AAP Clssification
Drug Reported effect
Acebutolol Hypotension; bradycardia; tachycardia
5-aminosalicylic acid Diarrhea
Atenolol Cyanosis; bradycardia
Bromocriptin Suppresses lactation; may be hazardous to the mother
Aspirin Metabolic acidosis
Clemastine Drowsiness irritability, refusal to feed, high-pitched cry, neck stiffness
Ergotamine Vomiting, diarrhea, convulsions
Lithium One-third to one-half therapeutic blood concentration in infants
Phenindione Anticoagulant; increased prothrombin and partial thromboplastin time in 1 infant;
not used in united states
Phenobarbital Sedation; infantile spasm after weaning from milk containing phenobarbital
Primidone Sedation feeding problems
Slfasalazine Bloody diarrhea
Drugs that have been association with significant effects on
some nursing infants and should be given to nursing mothers
with caution
Acetaminophen
Acetazolamide
Acitretin
Acyclovir
Alcohol (Ethanol)
Allopurinol
Amoxicilline
Antimony
Atropine
Azapropazone
Aztreonam
B1(Thiamin)
B6(Pyridoxine)
B12
Baclofen
Barbiturate
Bendroflumethiazide
Dicumarol
Bromide
Butorphanol
Caffeine
Captopril
Carbamazepine
Carbetocin
Carbimazole
Cascara
Cefadrxil
Cefazolin
Cefotaxime
AAP Clssification
Maternal medication usually compatible with breastfeeding
Cefoxetine
Cefprozil
Ceftazidime
Ceftriaxone
Chloral hydrate
Chloroform
Chloroquine
Chlorothiazide
Chlorothalidone
Cimetidine
Ciprofloxacin
Cisapride
Cisplatin
Clindamycin
Clogestone
Codeine
Colchicine
Oral contraceptive
pill with estr/proges
Cycloserine
D (vitamin)
Danthron
Dapson
Dexbrompheniramine
Diatrizoate
Digoxin
Diltiazem
Dipyrone
Disopyramide
Domperidone
Dyphylline
Enalpril
Erythromycin
Estradiol
Ethambutol
Ethosuximide
AAP Clssification
Maternal medication usually compatible with breastfeeding
Fentanyl
Fexofenadine
Flecainide
Fleroxacin
Fluconazole
Flufenamic acid
Fluorescein
Folic acid
Gadopentatic
Gentamicin
Gold salts
Halothane
Hydralazine
Hydrochlorothiazide
Hydroxychloroquine
Ibuprofen
Indomethacin
Iodides
Iodine
Iodine(Povidone-iodine)
Iohexol
Iopanoic acid
Isoniazid
Interferon
Ivermectine
K1(vitamin)
Kanamycin
Ketoconazole
Labetalol
Levonorgesterol
Lidocaine
Loperamide
Loratadine
Magnesium-
sulfate
AAP Clssification
Maternal medication usually compatible with reastfeeding
Medroxypro-
gesterone
Mefenamic acid
Meperidine
Methadone
Methimazole
Methohexital
Methyldopa
Methyprylon
Metoprolol
Metrizamide
Metrizoate
Mexiletine
Minoxidil
Morphine
Moxalactam
Nadolol
Nalidixic acid
Naproxen
Nefopam
Nifedipine
Nitrofurantoin
Norethynodrel
Norsteroids
Noscapine
Ofloxacin
Oxprenolol
Phenylbutazone
Phenytoin
Piroxicam
Prednisolone
Prednisone
Procainamide
Progesterone
Propoxyphene
Propranolol
AAP Clssification
Maternal medication usually compatible with breastfeeding
Propylthiouracil
Pseudoephedrine
Pyridostigmine
Pyrimethamine
Quinidine
Quinine
Riboflavin
Rifampin
Scopolamine
Secobarbital
Senna
Sotalol
Spironolactone
Streptomycin
Sulbactam
Sulfapyridine
Sulfisoxazole
Sumatriptan
Suprofen
Terbutaline
Terfenadine
Tetracycline
Theopylline
Thiopental
Thiouracil
Ticarcillin
Timolol
Tolbutamide
Tolmetin
Trimethprim/
Sulfamethoxazol
Triprolidine
Valproic acid
Verapamil
Warfarin
Zolpidem
AAP Clssification
Maternal medication usually compatible with breastfeeding
condition Recommended agents Use with caution
Allegic rhinitis
Beclomethasone
Fluticasone, cromolyn
Depression Sertraline, Paroxetine Fluoxetine,
Diabets
Insulin, Glyburide
Tolbutamide
Metformin
Thiazolinediones
Asthma Cromolyn, Nedocromil
Pain
Ibuprofen, Morphin
acetaminophen
Naproxen
meperidine
Contraception Barrier method
Estrogen-containing
contraceptives
Epilepsy Phenytoin, Carbamazepine Phenobarbital
Chaves RG 2004
Medications commonly prescribed for maternal ailments during
breastfeeding

More Related Content

What's hot

Substance misuse in pregnancy by dr alka mukherjee nagpur m.s. india
Substance misuse in pregnancy by dr alka mukherjee nagpur m.s. indiaSubstance misuse in pregnancy by dr alka mukherjee nagpur m.s. india
Substance misuse in pregnancy by dr alka mukherjee nagpur m.s. indiaalka mukherjee
 
Drug therapy in pregnancy and lactation
Drug therapy in pregnancy and lactationDrug therapy in pregnancy and lactation
Drug therapy in pregnancy and lactationVishnupriya K
 
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...Varsha Shah
 
Pediatric pharmacotherapy
Pediatric pharmacotherapyPediatric pharmacotherapy
Pediatric pharmacotherapyKaveh Kazemian
 
Drugs used in pregnancy
Drugs used in pregnancyDrugs used in pregnancy
Drugs used in pregnancyethan1hunt
 
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only PillsEmergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pillsmaria may dizon
 
Drugs used in pregnancy and lactation
Drugs used in pregnancy and lactationDrugs used in pregnancy and lactation
Drugs used in pregnancy and lactationKoppala RVS Chaitanya
 
Drug disposition in pregnancy
Drug disposition in pregnancyDrug disposition in pregnancy
Drug disposition in pregnancyAffShfq
 
Drugs used in lactation and pregnacy
Drugs used in lactation and pregnacyDrugs used in lactation and pregnacy
Drugs used in lactation and pregnacyWezi Kaonga
 
Oral contraceptives
Oral contraceptivesOral contraceptives
Oral contraceptivesLisaLemieux2
 

What's hot (20)

Drug use in pregnancy and lactation (2)
Drug use in pregnancy and lactation (2) Drug use in pregnancy and lactation (2)
Drug use in pregnancy and lactation (2)
 
Drug use in pregnancy and lactation part 3
Drug use in pregnancy and lactation part 3Drug use in pregnancy and lactation part 3
Drug use in pregnancy and lactation part 3
 
Substance misuse in pregnancy by dr alka mukherjee nagpur m.s. india
Substance misuse in pregnancy by dr alka mukherjee nagpur m.s. indiaSubstance misuse in pregnancy by dr alka mukherjee nagpur m.s. india
Substance misuse in pregnancy by dr alka mukherjee nagpur m.s. india
 
Breastfeeding
BreastfeedingBreastfeeding
Breastfeeding
 
Drugs used in lactation
Drugs used in lactationDrugs used in lactation
Drugs used in lactation
 
Infant feeding lit review
Infant feeding lit reviewInfant feeding lit review
Infant feeding lit review
 
Drug use in pregnancy and lactation part 1
Drug use in pregnancy and lactation part 1Drug use in pregnancy and lactation part 1
Drug use in pregnancy and lactation part 1
 
Drug use in pregnancy and lactation part 2
Drug use in pregnancy and lactation part 2Drug use in pregnancy and lactation part 2
Drug use in pregnancy and lactation part 2
 
Drug therapy in pregnancy and lactation
Drug therapy in pregnancy and lactationDrug therapy in pregnancy and lactation
Drug therapy in pregnancy and lactation
 
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
6 breastfeeding and drugs and acceptable medical reasons for artificial feedi...
 
Pediatric pharmacotherapy
Pediatric pharmacotherapyPediatric pharmacotherapy
Pediatric pharmacotherapy
 
Drugs used in pregnancy
Drugs used in pregnancyDrugs used in pregnancy
Drugs used in pregnancy
 
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only PillsEmergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
Emergency contraception, Combination Birth Control Pill, Progestogen-Only Pills
 
Drug use in pregnancy and lactation (3)
Drug use in pregnancy and lactation (3)Drug use in pregnancy and lactation (3)
Drug use in pregnancy and lactation (3)
 
Drugs used in pregnancy and lactation
Drugs used in pregnancy and lactationDrugs used in pregnancy and lactation
Drugs used in pregnancy and lactation
 
9pill
9pill9pill
9pill
 
Drug Safety in Pregnancy and Lactation
Drug Safety in Pregnancy and LactationDrug Safety in Pregnancy and Lactation
Drug Safety in Pregnancy and Lactation
 
Drug disposition in pregnancy
Drug disposition in pregnancyDrug disposition in pregnancy
Drug disposition in pregnancy
 
Drugs used in lactation and pregnacy
Drugs used in lactation and pregnacyDrugs used in lactation and pregnacy
Drugs used in lactation and pregnacy
 
Oral contraceptives
Oral contraceptivesOral contraceptives
Oral contraceptives
 

Viewers also liked

임신과 호흡기 질환 - 이은주
임신과 호흡기 질환 - 이은주임신과 호흡기 질환 - 이은주
임신과 호흡기 질환 - 이은주mothersafe
 
한국마더세이프전문상담센터 2013년 상반기 활동 현황
한국마더세이프전문상담센터 2013년 상반기 활동 현황한국마더세이프전문상담센터 2013년 상반기 활동 현황
한국마더세이프전문상담센터 2013년 상반기 활동 현황mothersafe
 
(마더세이프라운드) Embryogenesis - 제일병원 전이경 선생
(마더세이프라운드)  Embryogenesis - 제일병원 전이경 선생(마더세이프라운드)  Embryogenesis - 제일병원 전이경 선생
(마더세이프라운드) Embryogenesis - 제일병원 전이경 선생mothersafe
 
임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?
임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?
임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?mothersafe
 
(마더세이프라운드)임상연구에 필요한 통계 분석
(마더세이프라운드)임상연구에 필요한 통계 분석 (마더세이프라운드)임상연구에 필요한 통계 분석
(마더세이프라운드)임상연구에 필요한 통계 분석 mothersafe
 
국내 의약품의 안전관리 실태
국내 의약품의 안전관리 실태국내 의약품의 안전관리 실태
국내 의약품의 안전관리 실태mothersafe
 
Maternal nutrition
Maternal nutritionMaternal nutrition
Maternal nutritionmothersafe
 
Human Cardiac embryology - 전이경 교수
Human Cardiac embryology - 전이경 교수Human Cardiac embryology - 전이경 교수
Human Cardiac embryology - 전이경 교수mothersafe
 
Stress Incontinence
Stress IncontinenceStress Incontinence
Stress Incontinencemothersafe
 
2014 radiation.
2014 radiation.2014 radiation.
2014 radiation.mothersafe
 
임신 중 영양
임신 중 영양임신 중 영양
임신 중 영양mothersafe
 
임신 중 흡연 노출 평가-곽호석
임신 중 흡연 노출 평가-곽호석임신 중 흡연 노출 평가-곽호석
임신 중 흡연 노출 평가-곽호석mothersafe
 
한국마더리스크 소식지 제1호
한국마더리스크 소식지 제1호한국마더리스크 소식지 제1호
한국마더리스크 소식지 제1호mothersafe
 
&lt;마더리스크라운드> 알콜
&lt;마더리스크라운드> 알콜&lt;마더리스크라운드> 알콜
&lt;마더리스크라운드> 알콜mothersafe
 
What is Truth of Home Pregnancy Test Kit? 최준식교수
What is Truth of Home Pregnancy Test Kit? 최준식교수What is Truth of Home Pregnancy Test Kit? 최준식교수
What is Truth of Home Pregnancy Test Kit? 최준식교수mothersafe
 
Autoimmune diseas in pregnancy 김윤영
Autoimmune diseas in pregnancy 김윤영Autoimmune diseas in pregnancy 김윤영
Autoimmune diseas in pregnancy 김윤영mothersafe
 
마더세이프라운드 - 임신중부인암(이인호 교수)
마더세이프라운드 - 임신중부인암(이인호 교수)마더세이프라운드 - 임신중부인암(이인호 교수)
마더세이프라운드 - 임신중부인암(이인호 교수)mothersafe
 
만성질환을 앓는 예비임신부
만성질환을 앓는 예비임신부만성질환을 앓는 예비임신부
만성질환을 앓는 예비임신부mothersafe
 

Viewers also liked (19)

임신과 호흡기 질환 - 이은주
임신과 호흡기 질환 - 이은주임신과 호흡기 질환 - 이은주
임신과 호흡기 질환 - 이은주
 
한국마더세이프전문상담센터 2013년 상반기 활동 현황
한국마더세이프전문상담센터 2013년 상반기 활동 현황한국마더세이프전문상담센터 2013년 상반기 활동 현황
한국마더세이프전문상담센터 2013년 상반기 활동 현황
 
(마더세이프라운드) Embryogenesis - 제일병원 전이경 선생
(마더세이프라운드)  Embryogenesis - 제일병원 전이경 선생(마더세이프라운드)  Embryogenesis - 제일병원 전이경 선생
(마더세이프라운드) Embryogenesis - 제일병원 전이경 선생
 
임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?
임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?
임신 중 방사선(X-ray) 노출이 태아에 어떤 영향을 미칠까?
 
(마더세이프라운드)임상연구에 필요한 통계 분석
(마더세이프라운드)임상연구에 필요한 통계 분석 (마더세이프라운드)임상연구에 필요한 통계 분석
(마더세이프라운드)임상연구에 필요한 통계 분석
 
국내 의약품의 안전관리 실태
국내 의약품의 안전관리 실태국내 의약품의 안전관리 실태
국내 의약품의 안전관리 실태
 
Maternal nutrition
Maternal nutritionMaternal nutrition
Maternal nutrition
 
Human Cardiac embryology - 전이경 교수
Human Cardiac embryology - 전이경 교수Human Cardiac embryology - 전이경 교수
Human Cardiac embryology - 전이경 교수
 
Stress Incontinence
Stress IncontinenceStress Incontinence
Stress Incontinence
 
2014 radiation.
2014 radiation.2014 radiation.
2014 radiation.
 
임신 중 영양
임신 중 영양임신 중 영양
임신 중 영양
 
임신 중 흡연 노출 평가-곽호석
임신 중 흡연 노출 평가-곽호석임신 중 흡연 노출 평가-곽호석
임신 중 흡연 노출 평가-곽호석
 
한국마더리스크 소식지 제1호
한국마더리스크 소식지 제1호한국마더리스크 소식지 제1호
한국마더리스크 소식지 제1호
 
&lt;마더리스크라운드> 알콜
&lt;마더리스크라운드> 알콜&lt;마더리스크라운드> 알콜
&lt;마더리스크라운드> 알콜
 
What is Truth of Home Pregnancy Test Kit? 최준식교수
What is Truth of Home Pregnancy Test Kit? 최준식교수What is Truth of Home Pregnancy Test Kit? 최준식교수
What is Truth of Home Pregnancy Test Kit? 최준식교수
 
Autoimmune diseas in pregnancy 김윤영
Autoimmune diseas in pregnancy 김윤영Autoimmune diseas in pregnancy 김윤영
Autoimmune diseas in pregnancy 김윤영
 
마더세이프라운드 - 임신중부인암(이인호 교수)
마더세이프라운드 - 임신중부인암(이인호 교수)마더세이프라운드 - 임신중부인암(이인호 교수)
마더세이프라운드 - 임신중부인암(이인호 교수)
 
만성질환을 앓는 예비임신부
만성질환을 앓는 예비임신부만성질환을 앓는 예비임신부
만성질환을 앓는 예비임신부
 
Hyperemesis
HyperemesisHyperemesis
Hyperemesis
 

Similar to 수유 중 약물 복용의 상담 원칙2013

수유 중 약물 복용의 상담 원칙/안현경 교수
수유 중 약물 복용의 상담 원칙/안현경 교수수유 중 약물 복용의 상담 원칙/안현경 교수
수유 중 약물 복용의 상담 원칙/안현경 교수mothersafe
 
Behnke_Roussos-Ross_warner
Behnke_Roussos-Ross_warnerBehnke_Roussos-Ross_warner
Behnke_Roussos-Ross_warnerOPUNITE
 
Module-6_Perinatal-and-newborn-care.pptx
Module-6_Perinatal-and-newborn-care.pptxModule-6_Perinatal-and-newborn-care.pptx
Module-6_Perinatal-and-newborn-care.pptxpashblessings
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptxAzad Haleem
 
Pediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdiPediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdiAzad Haleem
 
Pharmacology part 5 (pregnancy)
Pharmacology part 5 (pregnancy)Pharmacology part 5 (pregnancy)
Pharmacology part 5 (pregnancy)NkosinathiManana2
 
pharmacotherapeutics in obstetrics. ppt
pharmacotherapeutics  in obstetrics. pptpharmacotherapeutics  in obstetrics. ppt
pharmacotherapeutics in obstetrics. pptFaraBegum
 
Nas treating pregnant_women_final
Nas treating pregnant_women_finalNas treating pregnant_women_final
Nas treating pregnant_women_finalOPUNITE
 
Paediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptxPaediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptx65NidheeshKumarPraba
 
Detoxification vs. Maintenance Treatment (methadone or buprenorphine) in Pre...
Detoxification vs. Maintenance Treatment  (methadone or buprenorphine) in Pre...Detoxification vs. Maintenance Treatment  (methadone or buprenorphine) in Pre...
Detoxification vs. Maintenance Treatment (methadone or buprenorphine) in Pre...ErikaAGoyer
 
Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...
Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...
Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...ErikaAGoyer
 
Induction of lactation in fostering mothers
Induction of   lactation   in   fostering   mothersInduction of   lactation   in   fostering   mothers
Induction of lactation in fostering mothersmuhammad al hennawy
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptxBAPIRAJU4
 
Drug therapy in Pregnancy
Drug therapy in PregnancyDrug therapy in Pregnancy
Drug therapy in PregnancyDr Manju prasad
 
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxGENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxkavitharaninachiya
 
Use of prescribed psychotropics during pregnancy
Use of prescribed psychotropics during pregnancyUse of prescribed psychotropics during pregnancy
Use of prescribed psychotropics during pregnancyRiaz Marakkar
 

Similar to 수유 중 약물 복용의 상담 원칙2013 (20)

수유 중 약물 복용의 상담 원칙/안현경 교수
수유 중 약물 복용의 상담 원칙/안현경 교수수유 중 약물 복용의 상담 원칙/안현경 교수
수유 중 약물 복용의 상담 원칙/안현경 교수
 
Behnke_Roussos-Ross_warner
Behnke_Roussos-Ross_warnerBehnke_Roussos-Ross_warner
Behnke_Roussos-Ross_warner
 
Ob addiction lecture addiction medicine (1)
Ob addiction lecture   addiction medicine (1)Ob addiction lecture   addiction medicine (1)
Ob addiction lecture addiction medicine (1)
 
Module-6_Perinatal-and-newborn-care.pptx
Module-6_Perinatal-and-newborn-care.pptxModule-6_Perinatal-and-newborn-care.pptx
Module-6_Perinatal-and-newborn-care.pptx
 
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
Pediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptxPediatric  Pharmacology:Pharmacokinetics and pharmacodynamics  .pptx
Pediatric Pharmacology:Pharmacokinetics and pharmacodynamics .pptx
 
Drug Excretion
Drug ExcretionDrug Excretion
Drug Excretion
 
Pediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdiPediatric pharmacology by dr.azad al.kurdi
Pediatric pharmacology by dr.azad al.kurdi
 
Pharmacology part 5 (pregnancy)
Pharmacology part 5 (pregnancy)Pharmacology part 5 (pregnancy)
Pharmacology part 5 (pregnancy)
 
pharmacotherapeutics in obstetrics. ppt
pharmacotherapeutics  in obstetrics. pptpharmacotherapeutics  in obstetrics. ppt
pharmacotherapeutics in obstetrics. ppt
 
Nas treating pregnant_women_final
Nas treating pregnant_women_finalNas treating pregnant_women_final
Nas treating pregnant_women_final
 
Paediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptxPaediatric Pharmacology Part-2.pptx
Paediatric Pharmacology Part-2.pptx
 
Pharma 2014
Pharma 2014Pharma 2014
Pharma 2014
 
Contraception
Contraception Contraception
Contraception
 
Detoxification vs. Maintenance Treatment (methadone or buprenorphine) in Pre...
Detoxification vs. Maintenance Treatment  (methadone or buprenorphine) in Pre...Detoxification vs. Maintenance Treatment  (methadone or buprenorphine) in Pre...
Detoxification vs. Maintenance Treatment (methadone or buprenorphine) in Pre...
 
Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...
Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...
Detoxification vs. Maintenance Treatment in Pregnancy – Jessica Young, MD, OB...
 
Induction of lactation in fostering mothers
Induction of   lactation   in   fostering   mothersInduction of   lactation   in   fostering   mothers
Induction of lactation in fostering mothers
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Drug therapy in Pregnancy
Drug therapy in PregnancyDrug therapy in Pregnancy
Drug therapy in Pregnancy
 
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptxGENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
GENERAL PRESCRIBING GUIDELINES FOR PAEDIATRIC PATIENTS.pptx
 
Use of prescribed psychotropics during pregnancy
Use of prescribed psychotropics during pregnancyUse of prescribed psychotropics during pregnancy
Use of prescribed psychotropics during pregnancy
 

More from mothersafe

장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주mothersafe
 
Safety of Mebendazole Use During Lactation
Safety of Mebendazole Use During LactationSafety of Mebendazole Use During Lactation
Safety of Mebendazole Use During Lactationmothersafe
 
Breastfeeding domeperiodne
Breastfeeding domeperiodneBreastfeeding domeperiodne
Breastfeeding domeperiodnemothersafe
 
(마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding (마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding mothersafe
 
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수mothersafe
 
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선mothersafe
 
Antiepileptics in pregnancy
Antiepileptics in pregnancyAntiepileptics in pregnancy
Antiepileptics in pregnancymothersafe
 
(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수mothersafe
 
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수mothersafe
 
(마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming (마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming mothersafe
 
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancymothersafe
 
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancymothersafe
 
Smoking in pregnancy
Smoking in pregnancySmoking in pregnancy
Smoking in pregnancymothersafe
 
(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancy(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancymothersafe
 
ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수mothersafe
 
2016 마더세이프 사업미팅
2016 마더세이프 사업미팅2016 마더세이프 사업미팅
2016 마더세이프 사업미팅mothersafe
 
임산부 영양상담
임산부 영양상담임산부 영양상담
임산부 영양상담mothersafe
 
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수mothersafe
 
(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식mothersafe
 
(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasd(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasdmothersafe
 

More from mothersafe (20)

장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
장애인 부부를 위한 임신·출산 매뉴얼, 40주의 우주
 
Safety of Mebendazole Use During Lactation
Safety of Mebendazole Use During LactationSafety of Mebendazole Use During Lactation
Safety of Mebendazole Use During Lactation
 
Breastfeeding domeperiodne
Breastfeeding domeperiodneBreastfeeding domeperiodne
Breastfeeding domeperiodne
 
(마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding (마더리스크라운드) Breastfeeding
(마더리스크라운드) Breastfeeding
 
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
(마더리스크라운드) Immunology in pregnancy /강원대 의대 나성훈 교수
 
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
(마더리스크라운드) Thyroid disease in pregnancy 임신 중 갑상선
 
Antiepileptics in pregnancy
Antiepileptics in pregnancyAntiepileptics in pregnancy
Antiepileptics in pregnancy
 
(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수(마더리스크라운드) Diclectin in NVP / 한정열 교수
(마더리스크라운드) Diclectin in NVP / 한정열 교수
 
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
Diclectin in NVP, 44th 유럽기형학회보고 / 한정열 교수
 
(마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming (마더리스크라운드) Developmental programming
(마더리스크라운드) Developmental programming
 
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
(마더리스크라운드) Determination of Isotretinoin & Acitretin in Pregnancy
 
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
(마더리스크 라운드) 임신 중 운동 exercise in pregnancy
 
Smoking in pregnancy
Smoking in pregnancySmoking in pregnancy
Smoking in pregnancy
 
(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancy(마더리스크라운드) Thyroid Disease in Pregnancy
(마더리스크라운드) Thyroid Disease in Pregnancy
 
ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수ECV 역아회전술- 한정열 단국대 의대 교수
ECV 역아회전술- 한정열 단국대 의대 교수
 
2016 마더세이프 사업미팅
2016 마더세이프 사업미팅2016 마더세이프 사업미팅
2016 마더세이프 사업미팅
 
임산부 영양상담
임산부 영양상담임산부 영양상담
임산부 영양상담
 
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수 (마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
(마더리스크라운드) 임신과 당뇨병 - 단국대의대 제일병원 김성훈 교수
 
(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식(마더리스크라운드) 임신 중 천식
(마더리스크라운드) 임신 중 천식
 
(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasd(마더리스크라운드) 임신 중 알콜 - fasd
(마더리스크라운드) 임신 중 알콜 - fasd
 

수유 중 약물 복용의 상담 원칙2013

  • 1. 수유 중 약물 복용의 상담 원칙 안 현경
  • 4. Healthy People 2010 Goals • Increase to at least 75% the proportion of mothers breastfeeding upon discharge and 50% still breastfeeding when the infant is 6 months of age. 0 10 20 30 40 50 60 70 80 90 100 1970 1995 1998 2010 Goal Discharge 6 Months
  • 5. 모유수유 중단요인 • 의료인의 권유 • 젖이 모자라서 • 함몰 유두 • 젖을 못 빨아서 • 물 젖이어서 • 유두가 아파서 • 기타 37.1% 18.8% 12.1% 10.5% 7.0% 6.1% 8.4% 이승주 등. 소아과 40: 1336
  • 6. Obstacles to Initiating and Continuing Breastfeeding • Physician apathy and misinformation • Insufficient pre-natal breastfeeding education • Distribution and promotion of infant formula • Disruptive hospital policies • Inappropriate interruptions of breastfeeding • Early hospital discharge • Lack of social support
  • 7. Role of the Physician • Establish positive attitudes in pregnancy • Address medical issues/ physical obstacles • Encourage nursing immediately after delivery • Provide post-partum support • Explain nutritional needs • Assess substance use • Discuss employment concerns
  • 8. Establish Positive Attitudes • Endorse and encourage breastfeeding because it is best for mother and baby. • Ask about previous experience • Provide positive statements about breastfeeding • Offer confirmatory words from all office staff • Distribute appropriate education materials • Be supportive no matter what the woman plans
  • 9. General Benefits of Breastfeeding • Maternal-infant bonding • Inexpensive • Convenient (no preparation) • Perfect temperature • Easily digested • Immunological protection • Allergy prophylaxis
  • 10. Breastfeeding Advantages for Mothers • May delay return of ovulation. • Loss of pregnancy associated adipose tissue. • Reduction in postpartum blood loss due to increased oxytocin levels. • Reduction in pre-menopausal breast cancer and reduced risk of ovarian cancer. • Improved bone remineralization postpartum.
  • 11. Immunological Contents of Breast Milk • Immunoglobulins – IgA, IgG, IgM, leukocytes, cytokines • Host resistance factors – Complement macrophages, lymphocytes, lactoferrin • Anti-inflammatory components – Enzymes: catalase, histaminase, lysozymes, lactoperoxidase – Antioxidants: acsorbic acid, alpha-tocopherol – Prostoglandins • Interleukin-6 – Stimulates an increase in mononuclear cells in breast milk.
  • 12. Breastfeeding Advantages for Baby • Decreased incidence and/or severity of otitis media, diarrhea, lower respiratory infections, bacteremia, bacterial meningitis, botulism, urinary tract infections, and necrotizing enterocolitis. • Less hospitalization in first 6 months. • Possible protective effect against sudden infant death syndrome, type 1 diabetes, Crohn’s disease, ulcerative colitis, lymphoma, allergies, and chronic digestive diseases.
  • 13. Drugs in Breastfeeding • Healthcare professionals should always encourage breastfeeding • Most drugs excreted into breast milk but usually in small amounts • Few drugs are absolutely contra-indicated • Some drugs may increase or decrease milk yield.
  • 14. Background - Mothers • 90% of women are prescribed a medication in first week postpartum • Mothers worry about effect of medication on nursing infant • Leads to: non compliance, weaning, avoidance of breastfeeding • 50% of mothers more reluctant to take a medication while nursing than during pregnancy
  • 15. Seven contraindications to breastfeeding (AAP 2 005) • Mother HIV + (in USA) • Use of illegal drugs by mother • Certain medications • Active, untreated TB in mother • Galactosemia in baby • Mother HTLV + • Herpes on breast
  • 16. How to decide if a medication or drug is ok? • Pharmacokinetic factors • Factors which govern drug transfer across membranes into breast milk as well as the metabolism of the drug in mother and infant
  • 17. Pharmacokinetic factors 1. Passive diffusion 2. Molecular weight 3. Protein binding 4. Lipid solubility 5. Half life 6. Oral bioavailability
  • 18. Passive diffusion • Drugs move in and out of breast milk • High to low • With time direction may shift • Example: alcohol
  • 19. Molecular weight • High molecular weight limits movement into breast milk • MW >500 daltons does not enter breast milk
  • 20. Molecular weight: examples • Insulin: MW > 6,000 daltons • Heparin: MW 40,000 daltons • Ethanol: MW 200
  • 21. Protein binding • Medications circulate in maternal circulation bound or unbound to albumin • Only unbound drug gets into maternal milk • Definition of good protein binding = > 90%
  • 22. Protein binding High protein binding • Propranolol 90% L2 • Diazepam 99% L3 Low protein binding • Lithium 0% L3
  • 23. Lipid solubility • Drugs that are very lipid soluble penetrate into breast milk in higher concentration • Drugs that are active in the CNS are drugs with high lipid solubility
  • 24. Half life Short half life drugs • Alcohol 24 min • Keflex 50 min • Ibuprofen 120 min • General anesthesia Long half life drugs • Prozac 216 hours
  • 25.
  • 26. Oral bioavailability • Amount of drug that is absorbed from the gut into the blood stream
  • 27. Oral bioavailability Drug Maternal GI Tract Maternal Plasma Breast Milk Infant GI Tract Infant Plasma
  • 28. Oral bioavailability • Low bioavailability may be due to – Reduced absorption in GI tract – Poor GI stability due to acidity – High first-pass uptake by liver
  • 29. Poor oral bioavailability • Gentamycin – <1% oral bioavailability • Insulin (destroyed in gut) – 0% oral bioavailability • Heparin (destroyed in gut)
  • 30. Drug Maternal gut and liver Maternal plasma Infant gut Infant plasma Oral bioavailability varies High (>90%) Low (<50%) Acetaminopen Acyclovir Lorazepam Azithromycin Metronidazole Budesonide Minoxidil Sulfasalazine Dilution of all drugs leads to low concentrations in mother’s plasma Only drugs are not protein-bound can pass into milk Drug protein binding High Low Bepridil >99% Bisoprolol 30% Diazepam 99% Cyclophosphamide 13% Diclofenac >99% Ranitidine 15% Propranolol 90% Primidone <20% Oral bioavailiability varies Usually very low levels (often undetectable) Route of drugs from mother to baby via breastmilk
  • 31. In general, baby gets <1% of maternal dose of drug
  • 32. Choice of Drug • Short acting • Highly protein bound • Low lipid solubility • High molecular weight • No active metabolites • Low oral bioavailability • Route of administration
  • 33. Drugs in Lactation – Factors to consider • Avoid unnecessary drug use and limit use of OTC products • Assess the benefit/risk ratio for both mother and infant • Avoid use of drugs known to cause serious toxicity in adults or children • Drugs licensed for use in infants do not generally pose a hazard • Neonates (esp premature infants) are at greater risk from exposure to drugs via breast milk • Route of administration (minimum amount of drug to the infant) • Avoid long-acting preparations • Monitor Infants exposed to drugs via breast milk for unusual signs/symptoms • Avoid new drugs if possible
  • 34. Drug transfer into the breast milk • Maternal factor – Dose and duration of therapy – Route of administration – Drug pharmacokinetics • Infant factor – Infant’s ability to absorb, metabolize, and excrete the drug – Gestational age of infant and its postnatal age
  • 35. Way to minimize infant drug exposure • Avoid feeding the infant at the time of peak concentration of the drug in milk. • Withhold breastfeeding temporarily if the drug is only used for a short duration. • Choose drugs for the mother that have known and established information about their pharmacokinetics and toxicity and have low concentrations in breast milk and low relative infant dose • Choose drugs that can be locally rather than systemically administered • In case of long-acting drugs, time the drug administration to a once- a-day dose just before the infant’s longest sleep period to lessen exposure.
  • 36. Evaluation of the infant • Infant age – Premature and newborn infants are at somewhat greater risk • Infant stability – Unstable infants with poor GI stability may increase the risk of using medications • Pediatric approved drugs – Generally are less hazardous if long-term history of safety is recognized • Dose – In a premature infant various doses may be more risky than in a 1 year old healthy infant • Drugs that alter milk production – May be much more risky during neonatal period than much later
  • 37. Summary • Nearly all drugs pass into human milk • Almost all medication appears in small amounts, usually less than 1% of the maternal dose • Very few drugs are contraindicated for nursing mothers
  • 38. LACTATION RISK CATEGORY BY THOMAS W HALE • L1 safest • L2 safer • L3 moderately safe • L4 possibly hazardous • L5 contraindicated
  • 39. DRUG CLASSIFICATION BY AAP • Cytotoxic drugs • Drugs of abuse for which adverse effects on the infant • Radioactive compounds that require temporary cessation of breastfeeding • Drugs for which the effect on nursing infants in unknown but may be concern • Drugs that have been associated with significant effects on some nursing infants and should be given to nursing mothers with caution • Maternal medication usually compatible with breastfeeding
  • 40. 상담 시 주지 사항 및 상담내용 • 약을 꼭 복용해야 하는지 평가한다. • 젖을 빨리고 난 다음 약을 복용한다. • 약물을 단기간 사용 할 경우에는 수유를 잠시 멈춘다. • 정확한 정보가 있는 약으로 아이에게 영향이 적은 약을 선택하게 한다. • 전신적으로 작용하는 약보다는 국소적으로 작용하는 약을 선택하게 한다.
  • 41. Reasons for using the telephone line in breastfeeding women Hemorrhoid CV disease GI disease Contraception Hepatitis B Respiratory disease Others Psychotic disease Nutrition Breast problem Dental disease Pain Inflamation Dermatologic disease Thyroid disease 12.5% 11% 9.6% 7.4%
  • 42. Antihistamine Regional agents Miscellaneous CV agents Nutritional agents Natural & Herbal pro Endocrine agents Respiratory agents Systemic antibiotics CNS agents & Analges GI drugs Drugs prescribed for breastfeeding women
  • 43.
  • 44. Drugs to avoid in the newborn and in infants < 6months of age • Beta-blocking agents – Acebutolol – Atenolol – Labetalol – Propranolol – Sotalol • Salicylates • Lithium • Antineoplastic agents • Drugs of abuse
  • 45. Cytotoxic drugs that may interfere with cellular metabolism of the nursing infant  Cyclophosphamide  Cycloserine  Doxorubicin  Methotrexate
  • 46. Drugs of abuse for which adverse effects on the infant during breastfeeding have been reported Drug Reported effect or reasons for concern Amphetamine Irritability, poor sleeping pattern Cocain Cocaine intoxication: irritability, vomiting, diarrhea, tremulousness. seizure Heroin Tremous, restlessness, vomiting, poor feeding Marijuana Only 1 report in literature; no effect mentioned; very long half-life for some components Phencyclidine Potent hallucinogen
  • 47. AAP Clssification Radioactive compounds that require temporary cessation of breastfeeding  Copper 64  Gallium 67  Indium 111  Iodine 123  Iodine 125  Iodine 131  Technetium 99  Radioactive sodium
  • 48. Anti-anxiety antidepressants antipsychotic Others Alprazolam Diazepam Lorazepam Midazolam Perphenazine Prazepam Quazepam Temazepam Amitryptiline Amoxapine Bupropion Clomipramine Desipramine Dothepine Doxepine Fluoxetine Fluvoxamine Imipramine Nortriptyline Paroxetine Sertraline Trazodone Chloropromazine Chlorprothixene Clozapine Haloperidol Mesoridazine Trifluoperazine Amiodarone Chloramphenicol Clofazimine Lamotrigine metronidazole Metoclopramide Tinidazole Drugs for which the effect on nursing infants is unknown but may be of concern AAP Clssification
  • 49. AAP Clssification Drug Reported effect Acebutolol Hypotension; bradycardia; tachycardia 5-aminosalicylic acid Diarrhea Atenolol Cyanosis; bradycardia Bromocriptin Suppresses lactation; may be hazardous to the mother Aspirin Metabolic acidosis Clemastine Drowsiness irritability, refusal to feed, high-pitched cry, neck stiffness Ergotamine Vomiting, diarrhea, convulsions Lithium One-third to one-half therapeutic blood concentration in infants Phenindione Anticoagulant; increased prothrombin and partial thromboplastin time in 1 infant; not used in united states Phenobarbital Sedation; infantile spasm after weaning from milk containing phenobarbital Primidone Sedation feeding problems Slfasalazine Bloody diarrhea Drugs that have been association with significant effects on some nursing infants and should be given to nursing mothers with caution
  • 51. Cefoxetine Cefprozil Ceftazidime Ceftriaxone Chloral hydrate Chloroform Chloroquine Chlorothiazide Chlorothalidone Cimetidine Ciprofloxacin Cisapride Cisplatin Clindamycin Clogestone Codeine Colchicine Oral contraceptive pill with estr/proges Cycloserine D (vitamin) Danthron Dapson Dexbrompheniramine Diatrizoate Digoxin Diltiazem Dipyrone Disopyramide Domperidone Dyphylline Enalpril Erythromycin Estradiol Ethambutol Ethosuximide AAP Clssification Maternal medication usually compatible with breastfeeding
  • 52. Fentanyl Fexofenadine Flecainide Fleroxacin Fluconazole Flufenamic acid Fluorescein Folic acid Gadopentatic Gentamicin Gold salts Halothane Hydralazine Hydrochlorothiazide Hydroxychloroquine Ibuprofen Indomethacin Iodides Iodine Iodine(Povidone-iodine) Iohexol Iopanoic acid Isoniazid Interferon Ivermectine K1(vitamin) Kanamycin Ketoconazole Labetalol Levonorgesterol Lidocaine Loperamide Loratadine Magnesium- sulfate AAP Clssification Maternal medication usually compatible with reastfeeding
  • 55. condition Recommended agents Use with caution Allegic rhinitis Beclomethasone Fluticasone, cromolyn Depression Sertraline, Paroxetine Fluoxetine, Diabets Insulin, Glyburide Tolbutamide Metformin Thiazolinediones Asthma Cromolyn, Nedocromil Pain Ibuprofen, Morphin acetaminophen Naproxen meperidine Contraception Barrier method Estrogen-containing contraceptives Epilepsy Phenytoin, Carbamazepine Phenobarbital Chaves RG 2004 Medications commonly prescribed for maternal ailments during breastfeeding